https://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-medtech-focused-vc-invests-e5-15m-in-clinical-to-commercial-stage-technologies-in-north-america-and-europe/Next Phase Newsletteren2026-10-20T16:49:25+00:00Hot Investor Mandate: Medtech-Focused VC Invests €5-15M in Clinical- to Commercial-Stage Technologies in North America and Europetechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-vc-firm-invests-from-seed-to-pre-ipo-in-novel-therapeutics-and-ai-enabled-healthcare-technologies-with-strong-ties-to-china/Next Phase Newsletteren2026-10-20T16:45:39+00:00Hot Investor Mandate: VC Firm Invests from Seed to Pre-IPO in Novel Therapeutics and AI-Enabled Healthcare Technologies, With Strong Ties to Chinatechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-global-deep-tech-vc-invests-in-healthcare-medtech-biotech-and-ai-with-southeast-asia-commercialization-support/Next Phase Newsletteren2026-10-20T16:45:21+00:00Hot Investor Mandate: Global Deep-Tech VC Invests in Healthcare, MedTech, Biotech, and AI with Southeast Asia Commercialization Supporttechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-cross-border-asia-based-vc-invests-in-life-sciences-and-healthcare-companies-with-strong-focus-on-therapeutics-and-drug-discovery-platforms/Next Phase Newsletteren2026-10-20T16:45:02+00:00Hot Investor Mandate: Cross-Border Asia-Based VC Invests in Life Sciences and Healthcare Companies, With Strong Focus on Therapeutics and Drug Discovery Platformstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/confirmed-investors-at-resi-jpm-2027/Next Phase Newsletteren2026-10-20T12:38:54+00:00RESI JPM 2027 on Track to Surpass Last Year’s 850 Investors and Licensing Partnersventure capital, Healthcare, news, entrepreneur, technology, startups, marketing, health, travel, AI, business, entrepreneurship, food, finance, investing, writing, books, beauty, education, social-media, lifestyle, facebook, twitter, adventurehttps://blog.lifesciencenation.com/2026/10/20/watch-the-asset-flow-not-the-equity-flow-what-i-learned-at-biojapan/Next Phase Newsletteren2026-10-20T12:38:32+00:00Watch the Asset Flow, Not the Equity Flow: What I Learned at BioJapanventure capital, Healthcare, news, science, technology, mental health, startups, marketing, health, travel, AI, japan, business, entrepreneurship, finance, investing, artificial-intelligence, art, writing, books, politics, digital-marketing, fitness, beauty, history, education, lifestyle, leadership, inspiration, chatgpt, sustainability, dailyprompthttps://blog.lifesciencenation.com/2026/10/20/synaptic-bio-first-place-ipc-winner-at-resi-boston-building-a-next-generation-checkpoint-therapy/Next Phase Newsletteren2026-10-20T12:38:06+00:00Synaptic Bio, First-Place IPC Winner at RESI Boston: Building a Next-Generation Checkpoint Therapynews, science, technology, mental health, interview, marketing, health, travel, AI, business, hotels, food, restaurants, artificial-intelligence, art, writing, books, nutrition, digital-marketing, poetry, fitness, cooking, recipes, beauty, wellness, photography, lifestyle, weight-loss, exercise, makeup, inspiration, baking, creativity